5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.90▼ | 1.90▼ | 1.88▲ | 2.06▼ | 2.06▼ |
MA10 | 1.85▲ | 1.86▲ | 1.88▲ | 2.21▼ | 1.68▲ |
MA20 | 1.87▲ | 1.95▼ | 2.02▼ | 2.10▼ | 1.37▲ |
MA50 | 2.04▼ | 2.15▼ | 2.20▼ | 1.56▲ | 1.20▲ |
MA100 | 2.20▼ | 2.19▼ | 2.06▼ | 1.32▲ | 1.12▲ |
MA200 | 2.10▼ | 1.86▲ | 1.64▲ | 1.24▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.020▲ | 0.010▲ | -0.004▼ | -0.077▼ | 0.096▲ |
RSI | 44.767▼ | 41.171▼ | 39.425▼ | 48.113▼ | 62.676▲ |
STOCH | 82.222▲ | 64.231 | 38.910 | 32.411 | 78.866 |
WILL %R | -26.667 | -43.590 | -74.419 | -85.101▼ | -40.571 |
CCI | 77.778 | 14.286 | -32.303 | -130.470▼ | 67.297 |
Sunday, June 15, 2025 09:30 PM
ATLANTA, June 16, 2025--Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data and parent company of the New York Stock Exchange (NYSE), today announced that ...
|
Friday, June 06, 2025 01:19 PM
NeuroSense Therapeutics, (NASDAQ:NRSN) operating under the Top Nasdaq Companies by Market Cap index, is part of the biotechnology sector focused on developing treatments for neurodegenerative diseases ...
|
Tuesday, May 13, 2025 11:11 AM
Fintel reports that on May 12, 2025, D. Boral Capital initiated coverage of NeuroSense Therapeutics (NasdaqCM:NRSN) with a Buy recommendation. Analyst Price Forecast Suggests 595.45% Upside As of ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/06/25 | 1.90 | 1.98 | 1.82 | 1.89 | 206,553 |
27/06/25 | 1.98 | 2.00 | 1.7657 | 1.90 | 566,637 |
26/06/25 | 2.17 | 2.19 | 1.84 | 1.98 | 610,475 |
25/06/25 | 2.28 | 2.28 | 2.09 | 2.20 | 190,340 |
24/06/25 | 2.16 | 2.35 | 2.16 | 2.31 | 184,010 |
23/06/25 | 2.33 | 2.3494 | 2.04 | 2.13 | 516,124 |
20/06/25 | 2.50 | 2.5199 | 2.28 | 2.35 | 283,024 |
18/06/25 | 2.41 | 2.48 | 2.3772 | 2.45 | 325,842 |
17/06/25 | 2.50 | 2.50 | 2.33 | 2.40 | 226,213 |
16/06/25 | 2.38 | 2.50 | 2.21 | 2.45 | 432,716 |
|
|
||||
|
|
||||
|
|